000 | 01925 a2200589 4500 | ||
---|---|---|---|
005 | 20250516153149.0 | ||
264 | 0 | _c20140403 | |
008 | 201404s 0 0 eng d | ||
022 | _a1432-1084 | ||
024 | 7 |
_a10.1007/s00330-013-2901-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaldorsen, Ingfrid S | |
245 | 0 | 0 |
_aDynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. _h[electronic resource] |
260 |
_bEuropean radiology _cOct 2013 |
||
300 |
_a2916-25 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aContrast Media |
650 | 0 | 4 |
_aEndometrial Neoplasms _xmortality |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImage Enhancement _xmethods |
650 | 0 | 4 |
_aMagnetic Resonance Imaging _xstatistics & numerical data |
650 | 0 | 4 | _aMeglumine |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xmortality |
650 | 0 | 4 |
_aNorway _xepidemiology |
650 | 0 | 4 | _aOrganometallic Compounds |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aGrüner, Renate | |
700 | 1 | _aHusby, Jenny A | |
700 | 1 | _aMagnussen, Inger J | |
700 | 1 | _aWerner, Henrica M J | |
700 | 1 | _aSalvesen, Oyvind O | |
700 | 1 | _aBjørge, Line | |
700 | 1 | _aStefansson, Ingunn | |
700 | 1 | _aAkslen, Lars A | |
700 | 1 | _aTrovik, Jone | |
700 | 1 | _aTaxt, Torfinn | |
700 | 1 | _aSalvesen, Helga B | |
773 | 0 |
_tEuropean radiology _gvol. 23 _gno. 10 _gp. 2916-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00330-013-2901-3 _zAvailable from publisher's website |
999 |
_c22804408 _d22804408 |